Who are Normal saline application's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Saline (NaCl).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/normal-saline-application.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-19 · How we verify

Normal saline application — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Normal saline application (Normal saline application) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte solution / Crystalloid fluid. Area: General supportive care / Fluid and electrolyte management.

marketed Electrolyte solution / Crystalloid fluid General supportive care / Fluid and electrolyte management Small molecule Live · refreshed every 30 min

Target snapshot

Normal saline application (Normal saline application) — Keimyung University Dongsan Medical Center. Normal saline is an isotonic sodium chloride solution that restores fluid balance and electrolyte homeostasis in the body.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Normal saline application TARGET	Normal saline application	Keimyung University Dongsan Medical Center	marketed	Electrolyte solution / Crystalloid fluid
Saline (NaCl)	Saline (NaCl)	VZW Cardiovascular Research Center Aalst	marketed	Electrolyte solution / Crystalloid fluid

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte solution / Crystalloid fluid class)

Keimyung University Dongsan Medical Center · 1 drug in this class
VZW Cardiovascular Research Center Aalst · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Normal saline application — Competitive Intelligence Brief. https://druglandscape.com/ci/normal-saline-application. Accessed 2026-05-19.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab